The global Artificial Blood market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Artificial Blood volume and value at global level, regional level and company level. From a global perspective, this report represents overall Artificial Blood market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Artificial Blood in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Artificial Blood manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Dextro-Sang Corporation
BioPure Corporation
Sangart
Northfield Laboratories
Baxter International
Dentritech
FluorO2 Therapeutics
Nuvox Pharma
Alpha Therapeutic Corporation
HemoBioTech

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Human Blood
Synthetic Blood
Animal Blood

Segment by Application
Hemoglobin-Based Oxygen Carriers (HBOCs)
Perflurocarbon Emulsions (PFCEs)